Research Report University Hospital of the clinical trial M025616

Abstract

Open-label Phase II single-arm to determine safety vismodegibe (GDC-0449) in patients with locally advanced or metastatic basal cell carcinoma

Keywords

• metastatic basal cell carcinoma
• vismodegibe (GDC-0449)